X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (112) 112
female (59) 59
middle aged (55) 55
male (53) 53
adult (47) 47
aged (47) 47
index medicus (43) 43
pathology (39) 39
microsatellite instability (35) 35
oncology (33) 33
mutation (32) 32
immunohistochemistry (30) 30
cancer (28) 28
tumors (26) 26
microsatellite repeats (23) 23
aged, 80 and over (20) 20
colorectal cancer (20) 20
genetic aspects (20) 20
biochemistry (18) 18
colorectal neoplasms, hereditary nonpolyposis - genetics (18) 18
beer (17) 17
chemistry (17) 17
compositions or test papers therefor (17) 17
condition-responsive control in microbiological orenzymological processes (17) 17
enzymology (17) 17
measuring or testing processes involving enzymes, nucleicacids or microorganisms (17) 17
metallurgy (17) 17
microbiology (17) 17
mutation or genetic engineering (17) 17
processes of preparing such compositions (17) 17
prognosis (17) 17
spirits (17) 17
vinegar (17) 17
wine (17) 17
analysis (16) 16
colon-cancer (16) 16
expression (16) 16
nonpolyposis colorectal-cancer (16) 16
base sequence (15) 15
colorectal neoplasms - genetics (15) 15
compositions thereof (15) 15
culture media (15) 15
dna methylation (15) 15
loss of heterozygosity (15) 15
microorganisms or enzymes (15) 15
polymerase chain reaction (15) 15
propagating, preserving or maintaining microorganisms (15) 15
microsatellite repeats - genetics (14) 14
mutl protein homolog 1 (14) 14
dna mutational analysis (13) 13
hnpcc (13) 13
mutations (13) 13
phenotype (13) 13
survival (13) 13
breast-cancer (12) 12
carcinoma (12) 12
digestive system diseases (12) 12
gene (12) 12
genetics & heredity (12) 12
health aspects (12) 12
research (12) 12
surgery (12) 12
animals (11) 11
cell biology (11) 11
gene expression (11) 11
time factors (11) 11
cell line, tumor (10) 10
medicine, research & experimental (10) 10
molecular sequence data (10) 10
proteins (10) 10
colorectal neoplasms - pathology (9) 9
colorectal-cancer (9) 9
mismatch repair (9) 9
mlh1 (9) 9
neoplasm proteins - metabolism (9) 9
neoplasm staging (9) 9
retrospective studies (9) 9
reverse transcriptase polymerase chain reaction (9) 9
adaptor proteins, signal transducing (8) 8
adenocarcinoma (8) 8
adenocarcinoma - genetics (8) 8
adolescent (8) 8
apoptosis (8) 8
biochemistry & molecular biology (8) 8
bladder-cancer (8) 8
carcinomas (8) 8
colorectal neoplasms, hereditary nonpolyposis - diagnosis (8) 8
deoxyribonucleic acid--dna (8) 8
dna repair (8) 8
dna-binding proteins - genetics (8) 8
gene expression regulation, neoplastic (8) 8
genes (8) 8
lasers (8) 8
methylation (8) 8
muts homolog 2 protein (8) 8
nuclear proteins - genetics (8) 8
young adult (8) 8
adenocarcinoma - pathology (7) 7
adenoma - genetics (7) 7
biomarkers, tumor - genetics (7) 7
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Cancer, ISSN 0008-543X, 03/2004, Volume 100, Issue 6, pp. 1199 - 1207
BACKGROUND Doxorubicin exhibits high efficacy in malignant glioma cell cultures. Nonetheless, as a standard formulation, doxorubicin has not been used... 
glioblastoma | pegylated liposomal doxorubicin | anaplastic astrocytoma | tamoxifen | Phase II trial | Tamoxifen | Pegylated liposomal doxorubicin | Anaplastic astrocytoma | Glioblastoma | RESPONSE CRITERIA | GLIOBLASTOMA-MULTIFORME | PHASE-II | DRUG-RESISTANCE | CHEMOTHERAPY | BRAIN-TUMORS | MALIGNANT GLIOMA | TRIAL | HIGH-DOSE TAMOXIFEN | ONCOLOGY | QUALITY-OF-LIFE | Immunohistochemistry | Doxorubicin - therapeutic use | Humans | Middle Aged | Tomography, Emission-Computed, Single-Photon | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Polyethylene Glycols - adverse effects | Male | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Polyethylene Glycols - therapeutic use | Tamoxifen - administration & dosage | Peptides - administration & dosage | Drug Carriers | Antineoplastic Agents - adverse effects | Doxorubicin - analogs & derivatives | Adult | Female | Doxorubicin - administration & dosage | Treatment Outcome | ATP-Binding Cassette, Sub-Family B, Member 1 - biosynthesis | Brain Neoplasms - drug therapy | Polyethylene Glycols - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Tamoxifen - therapeutic use | Survival Analysis | Quality of Life | Aged | Tamoxifen - adverse effects | Doxorubicin - adverse effects | Glioma - drug therapy | Peptides - adverse effects | Peptides - therapeutic use
Journal Article
International Journal of Cancer, ISSN 0020-7136, 04/2013, Volume 132, Issue 7, pp. 1537 - 1546
Journal Article
Journal Article
JDDG - Journal of the German Society of Dermatology, ISSN 1610-0379, 11/2018, Volume 16, Issue 11, pp. 1368 - 1371
Journal Article
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, ISSN 1610-0379, 11/2018, Volume 16, Issue 11, pp. 1368 - 1370
Journal Article
BMC Cancer, ISSN 1471-2407, 06/2010, Volume 10, Issue 1, pp. 302 - 302
Background: Cholangiocarcinoma (CC) is a malignant neoplasm of the bile ducts or the gallbladder. Targeting of growth factor receptors showed therapeutic... 
INSULIN | NUDE-MICE | CETUXIMAB | APOPTOSIS | INHIBITION | ONCOLOGY | UP-REGULATES P27(KIP1) | CHOLANGIOCELLULAR CARCINOMA | COLORECTAL-CANCER | MONOCLONAL-ANTIBODY | TUMOR-GROWTH | Proto-Oncogene Proteins c-met - metabolism | Receptor, Epidermal Growth Factor - genetics | ras Proteins - genetics | Proto-Oncogene Proteins p21(ras) | Apoptosis - drug effects | Humans | Gene Expression Regulation, Neoplastic | Cholangiocarcinoma - metabolism | RNA, Messenger - metabolism | Bile Ducts, Intrahepatic - drug effects | Dose-Response Relationship, Drug | Antibodies, Monoclonal, Humanized | Receptor, Epidermal Growth Factor - metabolism | Bile Ducts, Intrahepatic - metabolism | Receptors, Vascular Endothelial Growth Factor - metabolism | Time Factors | Antineoplastic Agents - pharmacology | Bile Duct Neoplasms - genetics | Cetuximab | Bile Ducts, Intrahepatic - pathology | Bile Duct Neoplasms - metabolism | Antibodies, Monoclonal - pharmacology | Proto-Oncogene Proteins - genetics | Cholangiocarcinoma - pathology | Receptors, Somatomedin - metabolism | Cell Line, Tumor | Cholangiocarcinoma - genetics | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Cell Proliferation - drug effects | Protein Kinase Inhibitors - pharmacology | Bile Duct Neoplasms - pathology | Mutation | Receptors, Growth Factor - metabolism | Gene mutations | Health aspects | Research
Journal Article
Journal Article
Journal Article
Molecular Cancer Therapeutics, ISSN 1535-7163, 03/2007, Volume 6, Issue 3, pp. 1123 - 1132
Oncogenic signaling through activation of epidermal growth factor receptor (EGFR), HER-2, and hypoxia inducible-factor-1α (HIF-1α) has been implicated in... 
tumor growth | heat-shock protein 90 | gastric cancer | epidermal growth factor receptor | angiogenesis | HSP90 INHIBITORS | OVEREXPRESSION | ANGIOGENESIS | ONCOLOGY | HYPOXIA-INDUCIBLE FACTOR-1-ALPHA | SHOCK-PROTEIN 90 | GELDANAMYCIN | BINDING PROTEIN | PHASE-I | EXPRESSION | RECEPTOR TYROSINE KINASE | Blood Vessels - growth & development | Muscle, Smooth, Vascular - metabolism | Pericytes - drug effects | Blood Vessels - metabolism | Humans | Receptor, ErbB-2 - metabolism | Stomach Neoplasms - metabolism | Male | Cell Line, Tumor - drug effects | Vascular Endothelial Growth Factor A - metabolism | Extracellular Signal-Regulated MAP Kinases - metabolism | Stomach Neoplasms - blood supply | Receptor, Epidermal Growth Factor - metabolism | Hypoxia-Inducible Factor 1, alpha Subunit - metabolism | Angiogenesis Inhibitors - therapeutic use | Fibroblasts - metabolism | Muscle, Smooth, Vascular - drug effects | Cell Hypoxia - drug effects | Enzyme-Linked Immunosorbent Assay | Pericytes - metabolism | Epidermal Growth Factor - metabolism | Lactams, Macrocyclic - pharmacology | Benzoquinones - pharmacology | Proto-Oncogene Proteins c-akt | Cell Movement - drug effects | Animals | HSP90 Heat-Shock Proteins - antagonists & inhibitors | Neovascularization, Pathologic - drug therapy | Fibroblasts - drug effects | Blood Vessels - drug effects | Cyclic AMP Response Element-Binding Protein - metabolism | HSP90 Heat-Shock Proteins - metabolism | Signal Transduction - physiology | Cell Proliferation - drug effects | Mice | Mice, Inbred BALB C | Mitogen-Activated Protein Kinases - metabolism
Journal Article